Alloksys Life Sciences BV

Our CFO, Herman Feil, delivered a compelling pitch at the Innovation for Health Congress on March 28th. Alloksys is executing a phase 3 study in patients undergoing cardiothoracic surgery with RESCAP®, building on promising phase 2b results. To support this study, Alloksys is seeking investment or a strategic partner to: • Accelerate and Extend the APPIRED III Study: Expanding our APPIRED III study, especially towards the US and UK, to include all major markets in our phase III clinicall study. • Execute Additional Clinical Studies: Exploring new therapeutic avenues such as burn wounds trauma and solid organ transplantation to address critical medical needs. • Scale Up Production of Bovine RESCAP®: Meeting demand by increasing production to ensure availability. • Investigate Alternative Sources for RESCAP®: Exploring native sources to diversify and enhance sustainability. • Further Develop ALLOKSYS as a Critical Care Medicine Company: Continuing our mission to redefine critical care medicine and drive innovation. Interested in joining us on this journey? Let's connect and explore how we can shape the future of RESCAP® together. 🌱 #Alloksys #Healthcare #Innovation #InvestmentOpportunity #ClinicalResearch #CriticalCare

🌟 Good News! Introducing the All-New Alloksys Website 🌐   Take a moment to explore our newly redesigned Alloksys website! 🚀   Our dedicated team has been hard at work, and we're delighted to present a sleek, user-friendly platform that provides deeper insights into our company and its pioneering solutions in critical care medicine.   Here's what you can explore on our new website: 🔬 In-depth information about our groundbreaking RESCAP treatment. 🧑⚕️ Access to scientific publications featuring alkaline phosphatase. 🌍 Stay updated with the latest news and developments as we continue to redefine critical care.   Visit us at https://alloksys.com to discover more about Alloksys and join us on our journey as we push the boundaries of medical innovation.   #CriticalCare #MedicalBreakthrough #HealthcareInnovation #Alloksys #RESCAP #CriticalCareMedicine #AlkalinePhosphatase #CardiothoracicSurgery #NewWebsite #Biotech #LifeSciences Giovanni van Dam MBA

Great piece in Fierce Biotech! https://lnkd.in/eQxRiYE4 #CriticalCare #MedicalBreakthrough #HealthcareInnovation #AlloksysLifeSciences #RESCAP #GameChanger #kidneydisease #criticalcaremedicine #alkalinephosphatase #cardiothoracicsurgery #kidneytreatment #renalhealth #criticalcare #qualityoflife

𝗕𝗥𝗘𝗔𝗞𝗜𝗡𝗚 𝗡𝗘𝗪𝗦 We're thrilled to share a breakthrough in critical care medicine that could revolutionize patient outcomes during and after major surgeries. In collaboration with experts in the field, Dutch @Alloksys has unveiled promising interim findings from its Phase IIb trial, evaluating the efficacy of its innovative Alkaline Phosphatase therapy, RESCAP®, in critical care patients undergoing cardiothoracic surgery.   The results are encouraging, showing a remarkable 30% reduction in the time required for hemodynamic stability when RESCAP® was administered to patients with a normal renal filtration rate before surgery, compared to a placebo. The study also demonstrated a notable 70% decrease in the likelihood of post-surgery acute kidney injury. These outcomes could revolutionize critical care practices, leading to quicker recovery and reduced healthcare costs.   With the Phase III trial commencing in Q3 2023, Alloksys is anticipating even more accelerated recovery and fewer complications for all enrolled patients due to extended RESCAP® administration.   The critical care medicine market, valued in the multi-billion-dollar range, focuses on managing life-threatening illnesses and injuries. Alloksys' RESCAP® could redefine the future of critical care, offering a potential game-changer in addressing life-threatening medical emergencies.   Link to press release: https://lnkd.in/e86bp5eQ   #CriticalCare #MedicalBreakthrough #HealthcareInnovation #AlloksysLifeSciences #RESCAP #GameChanger #kidneydisease #criticalcaremedicine #alkalinephosphatase #cardiothoracicsurgery #kidneytreatment #renalhealth #criticalcare #qualityoflife